Goserelin acetate before transurethral resection of moderately enlarged benign prostatic hyperplasia: Prospective randomised-controlled clinical trial

OBJECTIVE: To evaluate the impact of a luteinising hormone-releasing hormone (LHRH) agonist, goserelin acetate (GA), on surgical blood loss during transurethral resection of the prostate (TURP), as well as its histopathological effect on prostatic microvessel density (MVD). PATIENTS AND METHODS: Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Abo El-Enen, Mohamed, Tawfik, Ahmed, El-Abd, Ahmed S., Ragab, Maged, El-Abd, Sherin, Elrashidy, Mohamed, Elmashad, Nehal, Rasheed, Mohamed, El-Abd, Shawky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Prostatic Disorders Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767797/
https://www.ncbi.nlm.nih.gov/pubmed/26966595
http://dx.doi.org/10.1016/j.aju.2015.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767797/
https://www.ncbi.nlm.nih.gov/pubmed/26966595
http://dx.doi.org/10.1016/j.aju.2015.09.007

Ejemplares similares